The Argus Report Read about it!
The National Institutes of Health (NIH) has halted its clinical trial of hydroxychloroquine, saying that while there are no ill side effects, the anti-Malaria drug provides no benefit to COVID-19 patients."A data and safety monitoring board (DSMB) met late Friday and determined that while there was no harm, the study drug was very unlikely to be beneficial to…
Read More »NIH halts trial of hydroxychloroquine | TheHill
